van Linschoten, R. C. A., Jansen, F. M., Pauwels, R. W. M., Smits, L. J. T., Atsma, F., Kievit, W., de Jong, D. J., de Vries, A. C., Boekema, P. J., West, R. L., Bodelier, A. G. L., Gisbertz, I. A. M., Wolfhagen, F. H. J., Römkens, T. E. H., Lutgens, M. W. M. D., van Bodegraven, A. A., Oldenburg, B.
, Pierik, M. J., Russel, M. G. V. M., ... LADI study group, the Dutch Initiative on Crohn, Colitis (ICC) (2024).
A Prediction Model for Successful Increase of Adalimumab Dose Intervals in Patients with Crohn's Disease: Secondary Analysis of the Pragmatic Open-Label Randomised Controlled Non-inferiority LADI Trial.
Digestive diseases and sciences. Advance online publication.
https://doi.org/10.1007/s10620-024-08410-z